CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Search

We found 15 result(s)

CADTH Pharmaceutical Reviews Update — Issue 16

Last Updated: June 25, 2020
Result type: Reports
Product Line: Pharmaceutical Review Update

See Pharmaceutical Reviews Update – Issue 16 for important news and information related to CADTH’s drug review programs. Highlights from this issue include:

  • a consultation on CADTH’s drug reimbursement review procedures
  • a consultation on the Health Canada, CADTH, and INESSS aligned review ...

CADTH Pharmaceutical Reviews Update — Issue 14

Last Updated: March 4, 2020
Result type: Reports
Product Line: Pharmaceutical Review Update

See Pharmaceutical Reviews Update – Issue 14 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

  • A minor revision to the procedure for the sponsor’s review of initial CADTH pCODR Clinical and Economic Reports
  • Pending consultation o...

CADTH Pharmaceutical Reviews Update — Issue 13

Last Updated: February 6, 2020
Result type: Reports
Product Line: Pharmaceutical Review Update

Highlights from this issue include:

  • New consolidated document for pCODR procedures and guidelines
  • Clarifications regarding economic submission requirements
  • Update for patients and communities

CADTH Pharmaceutical Reviews Update — Issue 12

Last Updated: January 9, 2020
Result type: Reports
Product Line: Pharmaceutical Review Update

Highlights from this issue include:

  • A new process for the submission and review of cell and gene therapies
  • Updated guidelines on fees for CADTH pharmaceutical reviews
  • Pending updates to the category 1 requirements
  • Pending changes to CADTH conflict of interest policies
  • A reminder...

CADTH Pharmaceutical Reviews Update — Issue 11

Last Updated: November 21, 2019
Result type: Reports
Product Line: Pharmaceutical Review Update

Highlights from this issue include:

  • Information on the CADTH Drug Portfolio Information Session
  • A new interim plasma protein product review process
  • Details on the expansion of CADTH’s tailored review and therapeutic review processes
  • Revised processes for checkpoint meetings
  • Pend...

CADTH Pharmaceutical Reviews Update — Issue 10

Last Updated: August 22, 2019
Result type: Reports
Product Line: Pharmaceutical Review Update

Highlights from this issue include:

  • an extension of the feedback period on the ongoing consultations
  • an updated procedure for implementation-phase clinical panels
  • the upcoming announcement of a pilot process for plasma-related drugs.

CADTH Pharmaceutical Reviews Update — Issue 9

Last Updated: July 31, 2019
Result type: Reports
Product Line: Pharmaceutical Review Update

Updates for Patients and Communities CADTH is pleased to announce the membership of its new Patient and Community Advisory Committee. Twelve individuals from across the country have been invited to join the committee as inaugural members. Committee members are patients or family caregivers and reflect the diversity of people and communities ac...

CADTH Pharmaceutical Reviews Update — Issue 8

Last Updated: May 23, 2019
Result type: Reports
Product Line: Pharmaceutical Review Update

Updates for Patients and Communities Re-posting Calls for Patient Input CADTH has received some inquiries regarding how and when patient groups are re-engaged in the CADTH Common Drug Review (CDR) process following an initial call for patient input. In the case of a pending submission or resubmission, CADTH will repost the call for patient inp...

CADTH Pharmaceutical Reviews Update — Issue 7

Last Updated: April 17, 2019
Result type: Reports
Product Line: Pharmaceutical Review Update

CADTH Program Updates Common Drug Review 1. Additional Embargo Period Following Revised CDEC Recommendations Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to permit an additional embargo period for CADTH Canadian Drug Expert Committee (CDEC) recommendations that have been substantially revised follow...

CADTH Pharmaceutical Reviews Update — Issue 6

Last Updated: March 28, 2019
Result type: Reports
Product Line: Pharmaceutical Review Update

  • The latest news about CADTH’s new Patient and Community Advisory Committee.
  • Updates to the fee guidance for applications to CADTH’s Pharmaceutical Review Programs.
  • A summary of feedback from the August 2018 consultations on CADTH’s Pharmaceutical Review Programs.
  • Last call for submissions to the 2019 Oncol...